Pt Siloam International Hospitals Tbk Reg-s · IDX:SILO

Pt Siloam International Hospitals Tbk Reg-s — PT Siloam International Hospitals — Investor Presentation (2023)

63 slides from Pt Siloam International Hospitals Tbk Reg-s's investor presentation, 2023

  1. Slide 1: PT Siloam International Hospitals Tbk FY2022 Corporate Presentation

    Care and Compassion for the Nation PT Siloam International Hospitals Tbk FY2022 Corporate Presentation www.siloamhospitals.com

  2. Slide 2: Table of Contents

    Table of Contents Siloam Overview 3 Financial and Operational Update 8 Business Update 17 Digital Initiatives 13 26 21 Strategy and Initiatives 33 Corporate Governance Initiatives 37 CSR and ESG Initiatives 42 Siloam Transformation Team 46 Appendix 51

  3. Slide 3: Siloam Overview

    Siloam’ 63015 Siloam Overview

  4. Slide 4: Key Investment Highlights

    Largest private hospital networks in Indonesia spread 01 across 23 provinces throughout the entire archipelago Acknowledged leader in key medical specialties leading 02 to best-in-class revenue per bed Strong improvement in all aspects of financial results 03 since the consolidation strategy in 2019

  5. Slide 5: A Brief Introduction on Siloam Hospitals Group

    A Brief Introduction on Siloam Hospitals Group Vision Godly Reach Scale International Compassion Quality Mission “The trusted destination of choice for 41 Hospitals across 23 provinces in Indonesia holistic world class healthcare, health 1st hospital in Indonesia to be certified with education, and

  6. Slide 6: Largest Private Hospital Network in Indonesia Covering over 65% of Province

    Siloam Hospitals - Largest Private Hospital Network in Indonesia Covering over 65% of Province(1) JAKARTA Our Hospitals are delivered through 41 hospitals that are spread out in 23 provinces across Indonesia ▪ Siloam Hospitals Kebon Jeruk ▪ MRCCC Siloam Semanggi ▪ Siloam Hospitals TB Simatupang ▪ Si

  7. Slide 7: Acknowledged Leader in Medical Practices

    Acknowledged Leader in Medical Practices Leader in the Following Specialities Best in Class Average Revenue Per Bed ARPOB FY2022 (IDR bn) 3.3 Urology Pulmonology Oncology 2.0 1.3 Neurology Cardiology Siloam Hospital A Hospital B *Indicative results for Hospital A and Hospital B Medical Accomplishmen

  8. Slide 8: Financial and Operational Update

    Financial and Operational Update

  9. Slide 9: Siloam consistently develops Siloam 5.0 since 2019

    Siloam consistently develops Siloam 5.0 since 2019 and continuously achieve its financial targets Siloam 5.0 Journey Success Pillars to be Indonesia’s Preferred Healthcare Partner by providing Accessible & Holistic Care Financial Performance ● Customers ● Internal Business Process ● Learning & Growt

  10. Slide 10: FY2022 showed strong post Covid performance

    Siloam’s FY2022 showed strong post Covid performance, with increased contribution from base case Revenue Revenue booked at EBITDA increased to Net Profit increased to (in IDR bn) IDR7.39tn IDR1.98tn IDR710bn CAGR: 12.0% in 2022 in 2022 in 2022 3.2% | 28.4% 1.1% | 65.7% 1.5% | 467.2% 7,637 7,393 in F

  11. Slide 11: Financial Results CAGR 2018-2022

    Financial Results CAGR 2018-2022 Revenue* (IDR bn) EBITDA (IDR bn) 7,637 7,393 1,962 1,984 5,262 5,758 4,490 1,197 787 871 2018 2019 2020 2021 2022 2018 2019 2020 2021 2022 Net Profit (IDR bn) Operating Cash Flow (IDR bn) 700 710 125 2,027 26 1,652 1,337 -333 652 204 2018 2019 2020 2021 2022 2018 20

  12. Slide 12: Strong Post Covid performance from Q3 2022 onward

    Strong Post Covid performance from Q3 2022 onward Net Revenue* (IDR bn) EBITDA (IDR bn) and Margin (%) Net Profit (IDR bn) and Margin (%) 23.4% 24.4% 29.4% 29.3% 5.8% 6.6% 12.5% 12.6% 1,951 2,010 575 +14bn 589 244 +9bn 253 +266bn 1,747 -62bn 1,685 +16% +4% +163bn +40% +2.6% +120% +4% 409 +2bn 411 +1

  13. Slide 13: Operational Results per Quarter

    Operational Results per Quarter Operational Results per Quarter – Inpatient Admissions Operational Results per Quarter – Occupancy Rate (in 000) (in %) +3x% 68 +18% 66 56 50 +3% 51 +9% +13% 46 -14% 39 +28% 64.4 % 65.2 % 51.1 % 52.8 % 55.0 % 50.9% 51.0 % 51.3 % 55.1 % 41 -0.6% 41 4Q20 1Q21 2Q21 3Q21

  14. Slide 14: Working Capital Days

    Working Capital Days Inventory Days Receivables Days 45 55 34 43 FY 2021 FY 2022 FY 2021 FY 2022 Payables Days Working Capital Days 63 64 37 12 FY 2021 FY 2022 FY 2021 FY 2022 FY2022 Company Presentation 14

  15. Slide 15: Procurement efficiency measures driving Rp840bn savings

    Procurement efficiency measures have driven over Rp840bn savings for the next 5- years Medical Equipment Savings Hemodialysis Individual Procurement Bulk Procurement IDR >840bn Consolidated Savings Material Cost Savings Material cost has benefited from the formulary rationalization and therefore neg

  16. Slide 16: Proposed Dividend of FY2022 and Comparison to FY2021

    Proposed Dividend of FY2022 and Comparison to FY2021 (Subject to Shareholders’ Approval) Siloam proposed FY2022 dividend of Rp255bn with the details below, subject to Shareholders’ approval: 2022 2021 Proposed Dividend Declared (IDR bn) 255 250 Total Shares 12,959,756,000 1,616,742,625 Dividend per

  17. Slide 17: Business Update

    Siloam’ 63015 Business Update

  18. Slide 18: Revenue Growth by Payer Group

    Revenue Growth by Payer Group (IDR bn) % Contribution to Revenue FY21 vs FY22) 12.4% 0.8% Private (OPE, Corp + Insurance) BPJS MoH* 17.5% 12.6% Private patients’ (OPE, Corporate & Insurance) contribution continued show growth YoY 75.1% 81.7% FY21 FY22 Payee Group Contribution to Revenue (IDR bn) -4%

  19. Slide 19: Impact from Price Increase and Corporate and Insurance Clients Growth

    Impact from Price Increase and Corporate and Insurance Clients Growth Impact from Price Increase Corporate and Insurance Clients Growth Impact from Price Increase (IDR bn) No. of Accounts No. of New Accounts 200 200 +13.7% +5.8% 5,100 890 75-100 4,500 840 2022 2023 INA-CBGs 2021 2022 2021 2022 Siloa

  20. Slide 20: Patient-centric strategy lifts NPS scores in 2022

    Consistent delivery on improvement of operational productivity and focus of patient centric strategy has catapulted Siloam Hospitals NPS scores in 2022 NPS – Conducted by Siloam NPS – Conducted by External Party NPS (General Segment) – Conducted by IPSOS (2022) DEC YTD SILOAM (n=210) Hospital A (n=5

  21. Slide 21: Focusing on Expanding the Center of Excellences

    Siloam is Focusing on Expanding the Center of Excellences 8 Focus Areas Out of all the current existing clinical programs, Siloam has highlighted 8 as a national focus. Through analysis across preliminary metrics, of these 8, 4 to be fully Mom & Orthopedics developed as Center of Excellences focus i

  22. Slide 22: Siloam ASRI first private hospital certified for Kidney Transplant

    In 2022, Siloam Hospitals ASRI became the first private hospital to receive the Certificate of Recommendation for Kidney Transplant Procedure from the government Kidney Transplant Journey No. of Kidney Transplants Survival Rate 20 July 2017 2017 First kidney transplant procedure >200 Kidney Transpla

  23. Slide 23: Siloam Hospitals awarded as Stroke-ready Hospitals

    2 Siloam Hospitals have been awarded as Stroke-ready Hospitals with more units to follow Siloam is developing our partnership with Angels Initiative, a healthcare initiative that helps hospitals around the world become 'stroke- ready’, so that patients who have just suffered a stroke can be treated

  24. Slide 24: Blastula IVF program in Palembang above global benchmark

    Blastula IVF clinical program in Palembang outcome higher than global benchmark Blastula IVF Journey at SHPL Achievements IVF Cycles - 2022 21st January Soft Opening 576 IVF Cycles 73 19th March 64 64 1st Pregnancy 219 Insemination 59 2021 20th May Press Conference & Grand Opening 308 Successful Pre

  25. Slide 25: Optimizing performance through expansion of facilities and equipment

    Optimizing hospital’s performance through expansion of facilities, medical equipment and clinical offerings Siloam Hospitals Sentosa Expansion Radiotherapy at Siloam Hospitals Lippo Village SHST Expansion is expected to increase hospital Placement of LINAC at Siloam Hospitals Lippo capacity to 101 b

  26. Slide 26: Siloam Hospitals Digital Initiatives

    Siloam Hospitals Digital Initiatives

  27. Slide 27: Building Digital Patient Channels

    We are building Digital Patient Channels on our current infrastructure to deliver seamless, integrated patient experience Digital Transformation What we have achieved in 2022 Digitized Patient Voice Digitized Patient Voice 90 83 81 78 79 80 72 73 74 64 64 • Data Integrity (Digitalization and automat

  28. Slide 28: Investment in Digital Patients' Channels reaping benefits in 2022

    Siloam’s investment in Digital Patients’ Channels is reaping benefits in 2022 Siloam’s continuous investment in its digital patient platforms capability and engagement further increases patients’ experience. These digital channels, which include MySiloam App, Siloam’s website, dedicated contact cent

  29. Slide 29: Continue to Invest and Develop MySiloam App Functionality

    Continue to Invest and Develop MySiloam App Functionality Health Tips to access health-related articles My Health Tracker Book Medical History to track our health. Appointment to book an appointment with doctor Teleconsultation to consult your medical issue via online Hospital Information full infor

  30. Slide 30: Siloam Homecare Services

    Siloam Homecare Services In addition to Siloam’s extensive medical treatment offerings, Siloam provide homecare services for our patients who are physically unable to come to visit our doctors. With this facility, patients are able to consult with Siloam's doctors in the comfort of their homes. Curr

  31. Slide 31: Developing back-end IT infrastructure

    We are also continuously developing our back-end IT infrastructure Close Loop Medication Administration (CLMA) Electronic Medical Record (EMR) Adoption Pharmacy OPD EMR Adoption Model (EMRAM) - HIMSS Doctors EMR Adoption (OPD) Reached stage 5 97% EMR Adoption shows a stable trend, with all HUs alrea

  32. Slide 32: Seamless and comfortable patient experience supported by digital capabilities

    Siloam is maintaining its position by providing a more seamless and comfortable patient experience, supported by its digital capabilities Express Check-out Digitize Patient and Family Records Website and Apps Revamp Went live on Feb'23 Phase 1 and 2 to be launched in Q2 2023 Express Checkout Fresher

  33. Slide 33: Siloam's Strategy and Initiatives

    Siloam’s Strategy and Initiatives

  34. Slide 34: Four-Pillar Strategy

    Siloam 5.0 Strategy – Four Pillars of Growth Four-Pillar Strategy Clinical Network Core Growth Digital Health Programs Expansion Focus on business Develop clinical care Maximize existing Focus on business through partnership, for exhaustive and hospitalization through partnership, operational effici

  35. Slide 35: Revenue Growth Initiatives

    Revenue Growth Initiatives Procedure Packaging: Offering uniform pricing packages Value Based Pricing: Pricing management by reviewing and optimizing pricing across network Operational Effectiveness and Sales Team Engagement: Automation of the sales team and processes BPJS Optimization: Dedicated te

  36. Slide 36: Cost Management Initiatives

    Cost Management Initiatives Material Cost reduction: Optimize cost by consolidating supplier; re-negotiation with suppliers Demand Planning and Inventory Management: Improve working capital and reduce wasted consumable; shrinkage management OPEX Optimisation: Review operational process to optimize s

  37. Slide 37: Corporate Governance Initiatives

    Corporate Governance Initiatives

  38. Slide 38: Investment Committee: Robust Capital Allocation Controls

    Investment Committee: Robust Capital Allocation Controls • All Investment Plan/Projects above Roadmap (Gates) For New Hospital Openings IDR10,000,000,000 (ten billion Rupiah) SITE SELECTION PLANNING CONSTRUCTION MTC OPERATION and all new hospital Site identification and prioritisation Measuring, Mon

  39. Slide 39: Investment Committee: Robust Skills and Highly Experienced Members

    Investment Committee: Robust Skills and Highly Experienced Members Members of Investment Committee Peter John Chambers – Chairman Peter’s background includes over 25 years of experience in finance, telecommunication and investment oversight. He has occupied senior positions in various companies incl

  40. Slide 40: Strengthened Audit Committee

    Strengthened Audit Committee Siloam has revamped its audit committee. The current audit committee is chaired by Peter Chambers, with a strong reputation for administering good corporate governance. The audit committee has also invited Charles Rigoux from Gateway Partners, who brings with him an exte

  41. Slide 41: Robust Related Party Transaction Policy

    Corporate Governance: Robust Related Party Transaction Policy It is our belief that capital allocation All vendors go through a KYC All Related Party Transactions decisions should be made in the process and related parties need to (RPT) are reported to Siloam’s best interests of all shareholders. be

  42. Slide 42: Siloam CSR and ESG Initiatives

    Siloam CSR and ESG Initiatives

  43. Slide 43: Development of Siloam Clinics in Papua

    Development of Siloam Clinics in Papua Rural communities and people residing in remote areas have struggled to maintain access to quality health care services. One of the challenges in these areas is a shortage of physicians and other healthcare professionals. The unfavorable economies of scale make

  44. Slide 44: Supporting Indonesia's Medical Tourism Industry

    Supporting Indonesia’s Medical Tourism Industry Siloam is proud to play a part in supporting Indonesia’s medical tourism industry. Siloam is partnering with Indonesian government to enable 7 (seven) hospital units to become the recommended hospitals for tourists visiting Indonesia. List of hospitals

  45. Slide 45: Siloam ESG Campaign 2023 - #SELANGKAH

    Siloam ESG Campaign 2023 - #SELANGKAH: SEmangat LAwan KAnker Since 2022, the World Health Organization initiated the World Cancer Day theme "Close the Care Gap" to reduce gaps in cancer knowledge and care. Siloam Hospitals Group supports the world's fight against cancer in reducing gaps in access to

  46. Slide 46: Siloam Transformation Team

    Siloam Transformation Team 46

  47. Slide 47: Board of Directors

    Board of Directors Darjoto Setyawan - President Director Caroline Riady - Vice President dr. Grace Frelita Indradjaja – Director Darjoto brings with him more than 35 years Director dr Grace currently serves as Medical of experience in senior level management. Caroline started serving as Executive Ma

  48. Slide 48: Siloam Hospitals Board of Commissioners

    Siloam Hospitals Board of Commissioners John Riady - President Commissioner Dr Kartini Nurmala Panjaitan Syahrir - Independent Commissioner John currently serves as Director of PT Lippo Karawaci Tbk and Dr. Kartini serves as a Senior Advisor for Climate Change Issues to the various senior executive

  49. Slide 49: Key Management to Support Transformation

    Key Management to Support Transformation Varun Khanna – Managing Director of Healthcare Business & Dr. Julie McCaughan – Managing Director of Quality & Nursing Dr. Julie currently is the Quality and Nursing Managing Director of Siloam Investments Hospitals, she also helms Siloam Training Center as a

  50. Slide 50: Audit Committee: Independent with High Credentials Members

    Audit Committee: Independent with High Credentials Members Members of Audit Committee Peter John Chambers – Member Charles Rigoux – Member Peter’s background includes over 25 years of Charles is an investment professional at Gateway Partners, experience in finance, telecommunication and an investmen

  51. Slide 51: Appendix

    Siloam’ GHOSE Appendix

  52. Slide 52: 4Q2022 Financial Results Summary

    4Q2022 Financial Results Summary Revenue increased by EBITDA increased by EBITDA Margin grew to Revenue, EBITDA and Net Profit in 4Q22 increased by 15%, 39.8% and 15.0% 39.8% 29.3% 29.3% respectively compared with to and booked at in 4Q22 4Q21 where impact from COVID was IDR2.01tn IDR589bn from slow

  53. Slide 53: Monthly Revenue and EBITDA

    Monthly Revenue and EBITDA 2022 Monthly Revenue* (in IDR bn) 2022 Monthly EBITDA* (in IDR bn) 24% 23% 24% 20% 24% 27% 28% 32% 30% 26% 24% 39% 800 250 700 600 200 500 150 400 300 100 200 50 100 0 0 Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec *Revenu

  54. Slide 54: Siloam Hospitals Segments

    Siloam Hospitals Segments Total Cities: 25 Total Hospitals: 41 Total Provinces: 23 Segment Flagship Mature Distinct BPJS Ramping Up Description Well Profitable Operates in More than Hospitals established with high distinct niche 60% of opened in hospitals potential for markets with revenue is the la

  55. Slide 55: Siloam Hospitals Segments

    Siloam Hospitals Segments 3,784 Operational Beds 3,659 GPs, Specialists and Dentists 8,127 Nurses and Medical Staff 66 Siloam Clinics (7 clinics in Papua) Flagship Mature Distinct BPJS Ramping Up Well established hospitals Profitable with high Operates in distinct niche More than 60% of revenue Hosp

  56. Slide 56: Strategic Growth to Take Advantage of the Market Potential

    Siloam’s Strategic Growth to Take Advantage of the Market Potential 1996 2002 2011 2012 2013 2014 2016 2017 2018 2019 2020 2021 2022 IPO Right Issue Right Issue SH SH RSUS SH SH Bekasi SH RSU SH Surabaya Balikpapan Lippo Village ASRI Sepanjang Jaya Jember Kelapa Dua Ambon SH SH SH RSU SH SH Syubbanu

  57. Slide 57: Revenue per Patient Days and Outpatient Visits

    Revenue* per Patient Days and Outpatient Visits Average Revenue per Inpatient Days (in IDR mn) Average Revenue per Inpatient Days (in IDR mn) 7.3 6.9 -11% -8% 6.5 6.3 FY21 FY22 4Q21 4Q22 Average Revenue per Outpatient Visits (in IDR mn) Average Revenue per Outpatient Visits (in IDR mn) 1.6 1.4 -26%

  58. Slide 58: Operational Results per Region

    Siloam Hospitals Operational Results per Region Segment Region 1 Region 2 Region 3 Region 4 Region 5 East Java, Bali, East & West Area Jakarta & Greater Jakarta West & Central Java Sulawesi & Kalimantan Sumatera Nusa Tenggara and Maluku No. of Hospitals 9 10 9 7 5 4Q22 17 (+28%) 13 (+2%) 12 (+51%) 1

  59. Slide 59: Financial Results per Region

    Siloam Hospitals Financial Results per Region Segment Region 1 Region 2 Region 3 Region 4 Region 5 East Java, Bali, East & West Area Jakarta & Greater Jakarta West & Central Java Sulawesi & Kalimantan Sumatera Nusa Tenggara and Maluku No. of Hospitals 9 10 9 7 5 4Q22 1,165 (+10%) 316 (+26%) 399 (+29

  60. Slide 60: Operational Results by Segment

    Siloam Hospitals Operational Results by Segment Segment Flagship Mature Distinct BPJS Ramping Up Operates in distinct niche More than 60% of Well established hospitals with Profitable with high potential Hospitals opened in the last Description markets with high profitability revenue is derived from

  61. Slide 61: Financial Results by Segment

    Siloam Hospitals Financial Results by Segment Segment Flagship Mature Distinct BPJS Ramping Up Well established hospitals Profitable with high Operates in distinct niche More than 60% of Hospitals opened in the Description with high revenue and potential for further markets with high revenue is deri

  62. Slide 62: Top Shareholders

    Top 3 Shareholders PT Lippo Karawaci Tbk (Ownership CVC Capital Partners (Ownership Marubeni Group (Ownership as of as of 30 Dec 2022: 58.06%) as of 30 Dec 2022: 26.18%) 30 Dec 2022: 4.99%) PT Lippo Karawaci Tbk (ticker: LPKR) CVC Capital provides Siloam’s Marubeni Group is a well-known is the major

  63. Slide 63: Siloam Hospitals Head Office

    Siloam Hospitals Head Office Online Fakultas Kedokteran Universitas Pelita Harapan – 32nd Floor Website : www.siloamhospitals.com/investor-relations Jl. Boulevard Sudirman No. 15, Lippo Village Contact : Wily Tjandera (Investor Relations Senior Officer) Tangerang – Banten 15811, Indonesia wily.tjand

PT Siloam International Hospitals — Investor Presentation (2023) on 6ix